Relief Therapeutics Holding AG (RLFTF)

[theswordman]

The prespecified primary endpoint was death at or before day 60. Sabizabulin treatment resulted in a clinically and statistically meaningful 55% relative reduction in deaths (p=0.0029) in the intent to treat population. Placebo group (n=52) had a 45% mortality rate compared to the sabizabulin-treated group (n=98) which had a 20% mortality rate.
https://www.biospace.com/article/releases/veru-s-novel-covid-19-drug-candidate-reduces-deaths-by-55-percent-in-hospitalized-patients-in-interim-analysis-of-phase-3-study-independent-data-monitoring-committee-halts-study-early-for-overwhelming-efficacy/
___________________________________________________________
Corticosteroids: Overall, mortality in the treatment groups was 714 (25.6%) out of 2793, and in the control groups was 1365 (27.4%) out of 4973.

IL-6 MABS: Overall, mortality in the treatment group was 1545 (26.2%) out of 5899 and in the control group was 1043 (29.6%) out of 3528.

Hydroxychloroquine : Mortality in the treatment group was 628 (17.5%) out of 3589, and in the control group was 984 (19.2%) out of 5132.

Azithromycin : Including all studies mortality in the treatment group was 657 (20.7%) out of 3169, and in the control group was 1250 (21.2%) out of 5898.

https://err.ersjournals.com/content/30/162/210171

Something is NOT right in VERU placebo/SOC mortality numbers!!!!